What is it about?
This review aims to substantiate the hypothesis that antioxidant COX-2 inhibitors are promising radioprotectants because of intercepting radiation-induced oxidative stress and inflammation in normal tissue, especially the vascular system.
Featured Image
Read the Original
This page is a summary of: Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review, Antioxidants, April 2016, MDPI AG,
DOI: 10.3390/antiox5020014.
You can read the full text:
Contributors
The following have contributed to this page
